Autopsy report · NCT02907736

Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients

“replaced by a new study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Sponsor type

University, hospital or other

Conditions

Acute Stroke

Participants

0

Sites

1

Countries

France

Trials that died the same way

• MT2004-30: Tomotherapy for Solid Tumors
  “Replaced by another study” (95% match in meaning)
• Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
  “Replaced with another study” (94% match in meaning)
• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (80% match in meaning)
• A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
  “Study design was changed” (73% match in meaning)
• Fracture and Neurological Injury
  “A new version of the study will be submitted” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.